Amgen, Inc. (AMGN)
432.42
-4.57
(-1.05%)
USD |
NASDAQ |
Aug 28, 16:00
431.99
-0.43
(-0.10%)
After-Hours: 20:00
Amgen Free Cash Flow : 10.18B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.18B |
| March 31, 2026 | 8.597B |
| December 31, 2025 | 8.10B |
| September 30, 2025 | 11.54B |
| June 30, 2025 | 10.60B |
| March 31, 2025 | 10.92B |
| December 31, 2024 | 10.39B |
| September 30, 2024 | 6.283B |
| June 30, 2024 | 5.481B |
| March 31, 2024 | 7.098B |
| December 31, 2023 | 7.359B |
| September 30, 2023 | 9.379B |
| June 30, 2023 | 9.685B |
| March 31, 2023 | 7.531B |
| December 31, 2022 | 8.785B |
| September 30, 2022 | 8.997B |
| June 30, 2022 | 8.355B |
| March 31, 2022 | 8.417B |
| December 31, 2021 | 8.381B |
| September 30, 2021 | 7.84B |
| June 30, 2021 | 8.897B |
| March 31, 2021 | 9.835B |
| December 31, 2020 | 9.889B |
| September 30, 2020 | 10.24B |
| June 30, 2020 | 10.21B |
| Date | Value |
|---|---|
| March 31, 2020 | 8.795B |
| December 31, 2019 | 8.532B |
| September 30, 2019 | 9.175B |
| June 30, 2019 | 9.07B |
| March 31, 2019 | 9.715B |
| December 31, 2018 | 10.56B |
| September 30, 2018 | 10.45B |
| June 30, 2018 | 10.64B |
| March 31, 2018 | 10.87B |
| December 31, 2017 | 10.51B |
| September 30, 2017 | 10.43B |
| June 30, 2017 | 9.726B |
| March 31, 2017 | 9.975B |
| December 31, 2016 | 9.517B |
| September 30, 2016 | 8.598B |
| June 30, 2016 | 8.74B |
| March 31, 2016 | 9.031B |
| December 31, 2015 | 8.483B |
| September 30, 2015 | 8.735B |
| June 30, 2015 | 8.57B |
| March 31, 2015 | 7.943B |
| December 31, 2014 | 7.702B |
| September 30, 2014 | 7.229B |
| June 30, 2014 | 6.29B |
| March 31, 2014 | 5.677B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 12.94B |
| Regeneron Pharmaceuticals, Inc. | 3.575B |
| AbbVie, Inc. | 18.21B |
| Biogen, Inc. | 2.49B |
| Vertex Pharmaceuticals, Inc. | 3.796B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.002B |
| Cash from Investing (Quarterly) | -569.00M |
| Cash from Financing (Quarterly) | -1.482B |
| Free Cash Flow Per Share (Quarterly) | 6.414 |
| Free Cash Flow to Equity (Quarterly) | 3.508B |
| Free Cash Flow to Firm (Quarterly) | 4.077B |
| Free Cash Flow Yield | 4.33% |